The Maurice Wilkins Centre is working together to identify pathways to new treatments for diabetes and metabolic disease.
Disproportionately high rates of metabolic diseases – such as type-2 diabetes, obesity, cardiovascular disease, kidney disease, and gout – are contributing to health disparities in New Zealand. Also, current “one size fits all” treatments are not suitable for Māori and Pacific communities. Therefore, the Maurice Wilkins Centre Metabolic Health theme is committed towards identifying new treatments that are applicable to New Zealanders with type-2 diabetes and associated complications.
Previous MWC research demonstrate how unique genetic factors in Māori and Pacific peoples are contributing to metabolic diseases. Our goal is to improve patient outcomes through a better understanding of how certain genetic factors might be impacting on the effectiveness of current treatments, and develop new preventative or intervention strategies. There also remains a need to construct genetic profiles that are representative of New Zealand communities to better develop precision medicine for personalised therapies.